IMPACT OF FIX ACTIVITY ASSAY RESULTS DETERMINED WITH ONE-STAGE CLOTTING AND CHROMOGENIC ASSAYS ON THE CLASSIFICATION OF HAEMOPHILIA B

被引：0
|
作者：
Pavic, J. [1 ,2 ]
Milos, M. [3 ]
Herak, Coen D. [3 ]
Juros, Fressl G. [4 ]
Boban, A. [5 ]
Bilic, E. [6 ]
Salek, Zupancic S. [7 ]
Zadro, R. [8 ]
机构：
[1] Gen Cty Hosp Livno, Dept Med Biochem, Livno, Bosnia & Herceg
[2] Gen Cty Hosp Livno, Haematol Lab, Livno, Bosnia & Herceg
[3] Univ Hosp Ctr Zagreb, Dept Lab Diagnost, Zagreb, Croatia
[4] Srebrnjak Childrens Hosp, Dept Clin Lab Diagnost, Zagreb, Croatia
[5] Univ Hosp Ctr Zagreb, Dept Internal Med, Zagreb, Croatia
[6] Univ Hosp Ctr Zagreb, Dept Pediat, Zagreb, Croatia
[7] Univ Zagreb, Sch Med, Zagreb, Croatia
[8] St Catherine Specialty Hosp, Med Biochem Lab, Zagreb, Croatia
来源：
HAEMOPHILIA | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-09
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [31] FACTOR-VIII ACTIVITY AS MEASURED BY AN AMIDOLYTIC ASSAY COMPARED WITH A ONE-STAGE CLOTTING ASSAY
    TRIPODI, A
    MANNUCCI, PM
    RICERCA IN CLINICA E IN LABORATORIO, 1986, 16 (01): : 132 - 133
  • [32] Measurement of factor VIII activity of efraloctocog alfa with commercially available one-stage clotting and chromogenic assays: Results from the Belgian national External Quality Assessment Scheme
    Van Blerk, Marjan
    Chatelain, Bernard
    Devreese, Katrien
    Jacquemin, Marc
    Jochmans, Kristin
    Mullier, Francois
    Soumali, Mohamed R.
    Broeders, Sylvia
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 (01) : E20 - E22
  • [33] PHARMACOKINETICS OF FACTOR IX WITH ONE-STAGE AND CHROMOGENIC ASSAY IN HEMOPHILIA B AND CLINICAL OUTCOME
    Zulfikar, B.
    Koc, B.
    Aydin, F.
    HAEMOPHILIA, 2023, 29 : 20 - 21
  • [34] Novel mutations associated with a discrepancy between one-stage and chromogenic FVIII activity assay
    Provaznikova, D.
    Houskova, K.
    Radovska, A.
    Hrachovinova, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 833 - 833
  • [35] N9-GP activity can be measured using select one-stage clot assays and two-stage chromogenic assays in clinical samples from adults/adolescents and children with haemophilia B
    Young, G.
    Ezban, M.
    Clausen, W. H. O.
    Negrier, C.
    Oldenburg, J.
    Shima, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 : 57 - 57
  • [36] Fondaparinux anti-Xa activity: a comparison of one clotting assay and chromogenic substrate assays.
    Van Dreden, P
    Depasse, F
    Gerotziafas, GT
    Busson, J
    Fontaine, S
    Samama, MM
    BLOOD, 2003, 102 (11) : 120B - 121B
  • [37] Inter-Laboratory Evaluation of the Recovery of Bay 94-9027 [Jivi®] with One-Stage Clotting and Chromogenic Assays
    Meijer, Piet
    Marlar, Richard A.
    Teare, John M.
    Adcock, Dorothy
    BLOOD, 2019, 134
  • [38] REPRODUCIBILITY OF ONE-STAGE, 2-STAGE AND CHROMOGENIC ASSAYS OF FACTOR-VIII ACTIVITY - A MULTICENTER STUDY
    CINOTTI, S
    LONGO, G
    MESSORI, A
    MORFINI, M
    BLOMBACK, M
    SCHIMPF, K
    SCHUMACHER, K
    KJELLMAN, H
    NOVAKOVABANET, A
    DELVOS, U
    THROMBOSIS RESEARCH, 1991, 61 (04) : 385 - 393
  • [39] In vivo pharmacokinetics of recombinant factor VIII (recombinate) using one-stage clotting and chromogenic factor VIII assay.
    Lee, C
    Owens, D
    Lilley, P
    Giangrande, P
    Collins, P
    Hay, C
    Bray, G
    Gomperts, E
    Schroth, P
    Barrowscliffe, T
    BLOOD, 1997, 90 (10) : 143 - 143
  • [40] A global comparative field study to evaluate the factor VIII activity of efanesoctocog alfa by one-stage clotting and chromogenic substrate assays at clinical haemostasis laboratories
    Pipe, Steven
    Sadeghi-Khomami, Ali
    Konkle, Barbara A.
    Kitchen, Steve
    Negrier, Claude
    Liu, Mingjie
    Santagostino, Elena
    Willemze, Annemieke
    Abad-Franch, Lydia
    Knobe, Karin
    Seth Chhabra, Ekta
    HAEMOPHILIA, 2024, 30 (01) : 214 - 223
12345